The effects of LOXL2 on tumor infiltrated immune cells and oncogenic senescence have not yet been elucidated, it eagerly anticipates future exploration of the mechanisms underlying tumor advancement and the transition to a senescent state. The gene discussed is LOXL2; the disease is neoplasm.